Article Details

Current and Emerging Therapies for Relapsed and Refractory Multiple Myeloma

Retrieved on: 2021-08-11 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

Current and Emerging Therapies for Relapsed and Refractory Multiple Myeloma. View article details on hiswai:

Excerpt

The review authors noted that proteasome inhibitors, immunomodulatory drugs, and monoclonal antibodies (mAbs) are the main drug classes used in ...

Article found on: www.cancertherapyadvisor.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up